CAS4 Activators represent a category of chemical agents specifically identified for their capacity to enhance the expression of the CAS4 protein, a critical component of the CRISPR-Cas adaptive immune system in microorganisms. These activators encompass a diverse array of compounds that operate through various molecular mechanisms to upregulate the CAS4 gene at the transcriptional or post-transcriptional level. Some members of this class act epigenetically, modifying the accessibility of the CAS4 gene to transcription factors. For instance, histone deacetylase inhibitors (HDAC inhibitors) function by unwinding chromatin structure, thereby promoting the transcriptional activation of many genes, potentially including CAS4. Others, such as DNA methyltransferase inhibitors, could potentially demethylate the promoter regions of genes, leading to an increase in their expression. The specificity and selectivity of these chemicals vary, with some exhibiting broad effects across multiple gene networks, while others display more targeted actions.
Furthermore, CAS4 Activators may also include molecules that stabilize mRNA transcripts, thereby extending their lifespan within the cell and enhancing the translation of the CAS4 protein. Proteasome inhibitors fall into this class by preventing the degradation of proteins, indirectly leading to increased levels of a wide range of cellular proteins, including CAS4. In addition to these, compounds that modulate cellular signaling pathways can also serve as indirect activators. Such chemicals might influence the cascade of signals that regulate the expression of CAS4, adjusting the protein's levels in response to specific cellular states or environmental stimuli. The study of CAS4 Activators is primarily grounded in basic science, aiming to dissect and manipulate the fundamental biological processes and improve the understanding of gene regulation mechanisms in prokaryotic organisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING | 
|---|---|---|---|---|---|---|
| Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
| An HDAC inhibitor that could potentially upregulate CAS4 expression by increasing the accessibility of its promoter region to transcriptional machinery through chromatin remodeling. | ||||||
| 5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
| A DNA methyltransferase inhibitor that might activate CAS4 gene expression by reducing methylation levels at its promoter, thus allowing transcription factors to bind more effectively. | ||||||
| Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
| An mTOR inhibitor that may indirectly upregulate CAS4 by altering cellular growth signals, which could lead to a compensatory increase in CRISPR-Cas system components, including CAS4. | ||||||
| Tauroursodeoxycholic Acid, Sodium Salt | 14605-22-2 | sc-281165 | 1 g | $644.00 | 5 | |
| As a chemical chaperone, it could hypothetically promote CAS4 protein stability and enhance its levels by protecting it from misfolding and aggregation. | ||||||
| (±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
| A bromodomain inhibitor that might enhance CAS4 expression by disrupting the reading of acetylation marks on histones, potentially leading to a more transcriptionally active state of the CAS4 gene. | ||||||
| Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
| A proteasome inhibitor that may increase the quantity of CAS4 protein indirectly by inhibiting its degradation, thereby accumulating higher levels of the protein within the cell. | ||||||